Silk Road Medical, Inc
SILK · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.7% | 2.6% | 6.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.1% | 75.3% | 73.6% | 72.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27.2% | -23.7% | -21.9% | -22.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.4% | -29.2% | -27.5% | -28.8% |
| EPS Diluted | -0.42 | -0.36 | -0.33 | -0.33 |
| % Growth | -16.7% | -9.1% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |